Safety and preliminary efficacy of DFV890 in adult patients with myeloid diseases: A phase 1b study Meeting Abstract


Authors: Garcia-Manero, G.; Ooi, M.; Lao, Z. T.; Gill, H.; Abaza, Y.; Stahl, M.; Haque, T.; DeZern, A. E.; Greenberg, P. L.; Pelletier, M.; Singh, A.; Carreon, D.; Beaulieu, V.; Woo, J.
Abstract Title: Safety and preliminary efficacy of DFV890 in adult patients with myeloid diseases: A phase 1b study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3250
Language: English
ACCESSION: WOS:001159740303113
DOI: 10.1182/blood-2023-174642
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tamanna Haque
    9 Haque